U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Ceftolozane and Tazobactam (Zerbaxa) Injection
Status: Resolved
»Duration of Shortage: 01/04/2021 - 03/14/2022
»Therapeutic Categories: Anti-Infective

Merck Sharp & Dohme Corp. (Revised 03/14/2022)

Company Contact Information:
800-672-6372

Presentation
  • Supplied in single-dose vials containing ceftolozane 1 g (equivalent to 1.147 g of ceftolozane sulfate) and tazobactam 0.5 g (equivalent to 0.537 g of tazobactam sodium) per vial. Vials are supplied in cartons containing 10 vials (NDC 67919-030-01)
Note:
  • Available
Back to Top